American Journal of Bioethics

SJR Rank #2,049H-index: 81SJR: 1.651Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • Health PolicyQ1
  • Issues, Ethics and Legal AspectsQ1

Areas: Medicine · Nursing

Most published research topics

Ethics in medical practiceEthics in Clinical ResearchEthics and Legal Issues in Pediatric HealthcareBiomedical Ethics and RegulationPalliative Care and End-of-Life IssuesNeuroethics, Human Enhancement, Biomedical InnovationsPatient Dignity and PrivacyOrgan Donation and TransplantationHealthcare cost, quality, practicesReproductive Health and Technologies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250150300450600

Detailed Information

ISSN

1526-5161, 1536-0075

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

1.50

References per Document

16.27

Coverage

2001-2026

Scope

Every issue of AJOB contains peer-reviewed Target Articles that zero in on tough questions, answered by Open Commentary articles from scholars across disciplines and cultures. The American Journal of Bioethics provides an authoritative, annotated conversation that has been used by judges, Senators, journalists, scholars, schoolteachers, and millions of others as the key source on thousands of topics in the health sciences. AJOB leads the way in bioethics publishing. Hundreds of thousands more readers have discovered bioethics through InFocus articles and other features of bioethics.net. Our readers include faculty and students at virtually every graduate and professional school in the world, thousands of elected officials and judges, and most health news journalists. The American Journal of Bioethics has followed through on the innovative vision that built bioethics: serious discussion of the social implications of biomedicine.

Metrics from SCImago Journal Rank 2025. View on SCImago